Fed. Circ. Clears Boston Scientific In $200M Stent IP Case
The Federal Circuit on Friday upheld a decision clearing Boston Scientific Corp. in a cardiologist's contract suit seeking more than $200 million in royalties on his stent patents, concluding that the...To view the full article, register now.
Already a subscriber? Click here to view full article